An immunodominant mutation in the SPAS-1 protein was previously identified in this cell line, facilitating detection of tumor neoantigen-specific CD8+ T cells using MHC-I H-2Db tetramers loaded with the STHVNHLHC (H8) peptide36. This evidence concerns the gene CD8A and neoplasm.